Drug Prices

Medicare will negotiate the prices of top-selling drugs for blood clots, diabetes, cancer and arthritis, flexing newly granted…

We begin our coverage in Policy and Medicine Compliance Update this month by examining the complex world of medical education. The…

Recently, the Commonwealth of Kentucky filed a lawsuit against pharmacy benefit managers (PBMs) and drug manufacturers over the…

The Biden administration has released new guidance for its program that will allow Medicare to directly negotiate the prices of…

Recently, Merck & Co sued the United States Department of Health and Human Services (HHS) and Centers for Medicare and…

During the April 2023 Medicare Payment Advisory Commission (MedPAC) meeting, the Commission unanimously approved three…

Reuters recently reported that some of the largest pharmaceutical companies are planning to fight the United States plan to…

The Pharmaceutical Research and Manufacturers of America (PhRMA) recently published a new report that analyzes the share of new…

On March 15, 2023, CMS released initial guidance detailing the requirements and parameters on key elements of the new Medicare…

Ohio Attorney General David Yost filed a lawsuit against Ascent Health Services, Express Scripts Inc., Cigna Group, Evernorth…